SCHEMBL138661

SCHEMBL138661

C=CC(=O)NCCCOC

nearest known ligand 0.58

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
ZDHHC20 Q5W0Z9 1/20 0.58
ZDHHC2 Q9UIJ5 1/20 0.58
TSHR P16473 2/20 0.55
ALDH1A1 P00352 3/20 0.52
CYP1A2 P05177 2/20 0.49
RECQL P46063 1/20 0.49
HPGD P15428 2/20 0.48
GAA P10253 3/20 0.47
TDP1 Q9NUW8 2/20 0.46
MAPK1 P28482 1/20 0.46
MEN1 O00255 1/20 0.44
KMT2A Q03164 1/20 0.44
CYP2C19 P33261 1/20 0.44
EPHX2 P34913 2/20 0.44
POLB P06746 1/20 0.42
SMN1; SMN2 Q16637 1/20 0.42
TGM2 P21980 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2612009 0.94 ZDHHC20 (0.61) ZDHHC20ZDHHC2TSHRALDH1A1CYP1A2
SCHEMBL26688131 0.93 ZDHHC20 (0.51) ZDHHC20ZDHHC2TSHRALDH1A1CYP1A2
SCHEMBL14996294 0.92 ZDHHC20 (0.65) ZDHHC20ZDHHC2TSHRALDH1A1CYP1A2
SCHEMBL9721438 0.89 ZDHHC20 (0.51) ZDHHC20ZDHHC2TSHRALDH1A1CYP1A2
SCHEMBL69447 0.88
Acetone SCHEMBL9465817 0.84 ZDHHC20 (0.48) ZDHHC20ZDHHC2TSHRALDH1A1HPGD
SCHEMBL10030961 0.84 ZDHHC20 (0.53) ZDHHC20ZDHHC2TSHRALDH1A1CYP1A2
SCHEMBL12328963 0.83 ZDHHC20 (0.57) ZDHHC20ZDHHC2TSHRALDH1A1RECQL
SCHEMBL24715024 0.82 ZDHHC20 (0.55) ZDHHC20ZDHHC2TSHRALDH1A1HPGD
SCHEMBL19141793 0.82 ZDHHC20 (0.55) ZDHHC20ZDHHC2TSHRALDH1A1GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1161 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-122044898-A Strong isolation MCS system based on single SOC chip and implementation method 湖北芯擎科技股份有限公司 2026-05-15 CN claimed
CN-122036353-A Nanopowder, nanoceramic materials, and methods of making and using the same 应用材料公司 2026-05-15 CN claimed
US-12595396-B2 Acid resistant filter media ENTEGRIS, INC. (US) 2026-04-07 US claimed
US-20260042870-A1 BINDER COMPOSITIONS AND USES THEREOF KNAUF INSULATION SPRL (BE) 2026-02-12 US claimed
WO-2025264622-A1 MULTI-COMPONENT RESPONSIVE COPOLYMERS AND APPLICATIONS THEREOF AESCULA TECH, INC. (US) 2025-12-26 WO claimed
US-20250382404-A1 MULTI-COMPONENT RESPONSIVE COPOLYMERS AND APPLICATIONS THEREOF AESCULATECH INC (US) 2025-12-18 US claimed
US-12472260-B2 Antibody biopharmaceutical formulations including polymer excipients THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY (US) 2025-11-18 US claimed
EP-4646188-A1 INJECTABLE FORMULATION COMPRISING A BIOPHARMACEUTICAL AGENT AND A POLYACRYLAMIDE-BASED COPOLYMER The Board of Trustees of the Leland Stanford Junior University (US) 2025-11-12 EP claimed
US-20250339536-A1 BIOPHARMACEUTICAL FORMULATIONS INCLUDING POLYMER EXCIPIENTS UNIV LELAND STANFORD JUNIOR (US) 2025-11-06 US claimed
CN-120126136-A Unmanned aerial vehicle autonomous air refueling target segmentation and detection method imitating prey bird vision 北京航空航天大学 2025-06-10 CN claimed
US-20050025741-A1 Copolymers with (meth)acrylamides; improved separation of polynucleotides APPLIED BIOSYSTEMS, LLC 2005-02-03 US claimed
WO-2004104054-A1 POLY AND COPOLY (N-VINYLAMIDE)S AND THEIR USE IN CAPILLARY ELECTROPHORESIS APPLERA CORPORATION (US) 2004-12-02 WO claimed
WO-2004011513-A1 GRAFT COPOLYMERS, THEIR PREPARATION AND USE IN CAPILLARY ELECTROPHORESIS APPLERA CORPORATION (US) 2004-02-05 WO claimed
EP-0664729-B1 IMPLANTABLE AND REFILLABLE BIOHYBRID ARTIFICIAL PANCREAS UNIV UTAH (US) 1998-01-21 EP claimed
EP-0664729-A4 IMPLANTABLE AND REFILLABLE BIOHYBRID ARTIFICIAL PANCREAS. UNIV UTAH (US) 1996-03-27 EP claimed
US-5484610-A pH and temperature sensitive terpolymers for oral drug delivery MACROMED, INC. (US) 1996-01-16 US claimed
EP-0664729-A1 IMPLANTABLE AND REFILLABLE BIOHYBRID ARTIFICIAL PANCREAS THE UNIVERSITY OF UTAH (US) 1995-08-02 EP claimed
WO-1994008702-A1 IMPLANTABLE AND REFILLABLE BIOHYBRID ARTIFICIAL PANCREAS UNIVERSITY OF UTAH (US) 1994-04-28 WO claimed
US-5262055-A FOR USE IN THE TREATMENT OF DIABETES THE UNIVERSITY OF UTAH (US) 1993-11-16 US claimed
US-5093030-A Emulsion polymerizing an acrylamide, crosslinking, removing surfactant AGENCY OF INDUSTRIAL SCIENCE AND TECHNOLOGY (JP) 1992-03-03 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260042870-A1 BINDER COMPOSITIONS AND USES THEREOF SMCHD1, VCL, FGB ZDHHC20 4177/4885ZDHHC2 3851/4885TSHR 4450/4885
US-12595396-B2 Acid resistant filter media SDC2, F7, SDC1 ZDHHC20 2994/4885ZDHHC2 2683/4885TSHR 647/4885
US-20050025741-A1 Copolymers with (meth)acrylamides; improved separation of polynucleotides POLI, PCNA, POLL ZDHHC20 4333/4885ZDHHC2 4036/4885TSHR 4259/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.